LifeMD (NASDAQ:LFMD) Announces Earnings Results

LifeMD (NASDAQ:LFMD) announced its earnings results on Monday. The company reported ($0.02) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.02, Zacks reports.

LifeMD Stock Performance

Shares of LFMD stock traded down $0.40 on Monday, hitting $4.27. 3,045,729 shares of the company’s stock traded hands, compared to its average volume of 779,838. The company’s fifty day simple moving average is $5.66 and its 200 day simple moving average is $5.38. LifeMD has a one year low of $3.99 and a one year high of $12.88. The stock has a market capitalization of $184.94 million, a price-to-earnings ratio of -6.67 and a beta of 1.50.

Analysts Set New Price Targets

Several research analysts have commented on LFMD shares. KeyCorp lowered their price objective on shares of LifeMD from $10.00 to $7.00 and set an “overweight” rating for the company in a research report on Wednesday, January 8th. Lake Street Capital began coverage on LifeMD in a report on Tuesday, December 10th. They issued a “buy” rating and a $12.00 target price for the company. HC Wainwright restated a “buy” rating and set a $12.00 price objective on shares of LifeMD in a report on Monday, November 11th. Finally, Mizuho assumed coverage on LifeMD in a report on Wednesday, December 4th. They set a “neutral” rating and a $7.00 price objective on the stock. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, LifeMD currently has a consensus rating of “Moderate Buy” and an average price target of $11.14.

Insider Activity

In other LifeMD news, CEO Justin Schreiber sold 50,000 shares of the firm’s stock in a transaction on Friday, February 14th. The shares were sold at an average price of $7.55, for a total value of $377,500.00. Following the sale, the chief executive officer now owns 2,653,715 shares of the company’s stock, valued at $20,035,548.25. This trade represents a 1.85 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 15.97% of the company’s stock.

LifeMD Company Profile

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.